Kura Oncology
KURA
KURA
133 hedge funds and large institutions have $687M invested in Kura Oncology in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 64 increasing their positions, 34 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
63% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 24
77% less call options, than puts
Call options by funds: $201K | Put options by funds: $892K
Holders
133
Holding in Top 10
4
Calls
$201K
Puts
$892K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$6.96M | |
| 3 | +$5.37M | |
| 4 |
SCM
Suvretta Capital Management
New York
|
+$2.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.51M |
Top Sellers
| 1 | -$9.17M | |
| 2 | -$6.66M | |
| 3 | -$5.29M | |
| 4 |
EP
Eversept Partners
New York
|
-$4.77M |
| 5 |
Goldman Sachs
New York
|
-$4.28M |